Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors

Frankie Poon,Rangarajan Sambathkumar,Roman Korytnikov,Yasaman Aghazadeh,Amanda Oakie,Paraish S. Misra,Farida Sarangi,M. Cristina Nostro
DOI: https://doi.org/10.1038/s41467-024-53068-w
2024-10-10
Organogenesis
Abstract:Human pluripotent stem cells (hPSCs) have the potential to differentiate into various cell types, including pancreatic insulin-producing β cells, which are crucial for developing therapies for diabetes. However, current methods for directing hPSC differentiation towards pancreatic β-like cells are often inefficient and produce cells that do not fully resemble the native counterparts. Here, we report that highly selective tankyrase inhibitors, such as WIKI4, significantly enhances pancreatic differentiation from hPSCs. Our results show that WIKI4 promotes the formation of pancreatic progenitors that give rise to islet-like cells with improved β-like cell frequencies and glucose responsiveness compared to our standard cultures. These findings not only advance our understanding of pancreatic development, but also provide a promising new tool for generating pancreatic cells for research and potential therapeutic applications. "Here the authors demonstrate that ß cell differentiation from human pluripotent stem cells can be improved by replacing nicotinamide with tankyrase inhibitors. This results in pancreatic progenitors that form islet-like cells with increased ß cell frequencies and glucose responsiveness."
engineering, biomedical,biochemistry & molecular biology,developmental biology
What problem does this paper attempt to address?